Analysis of the anorectic efficacy of HMR1426 in rodents and its effects on gastric emptying in rats

被引:3
作者
Bickel, M
Gossel, M
Geisen, K
Jaehne, G
Lang, HJ
Rosenburg, R
Sandow, J
机构
[1] Aventis Pharma Deutschland GmbH, Pharmacol DI&A Metab Dis, D-65926 Frankfurt, Germany
[2] Aventis Pharma Deutschland GmbH, Med Chem, D-65926 Frankfurt, Germany
[3] Aventis Pharma Deutschland GmbH, Clin Discovery & Human Pharmacol, D-65926 Frankfurt, Germany
关键词
HMR1426; analysis of feeding behavior; gastric emptying; sham feeding; rodents;
D O I
10.1038/sj.ijo.0802540
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES: Pharmacodynamics of HMR1426 in rodents. SUBJECTS: Male and female rats and male mice. MEASUREMENTS: 24 h feed consumption was measured. From the time curves IC50 values of HMR1426 were calculated. Microanalysis of feeding behavior was determined. Macronutrient preference was measured, by offering rats three different diets. Gastric emptying was measured after liquid gastric loads or solid meals. In rats with gastric cannulas, milk consumption was measured with closed or open cannulas. Diabetes-related parameters and thyroid hormones were measured. RESULTS: HMR1426 inhibited feed consumption dose-dependently in rodents. Microstructural analysis of feeding after HMR1426 differed from central acting anorectics. HMR1426 inhibited consumption of fat- and carbohydrate-enriched diets. Gastric empyting was dose- and time-dependently delayed. Gastric emptying correlated with the time course of the anorectic effect. In sham-fed rats, HMR1426 had no anorectic effect with open cannulas. Anorectic effect occurred with closed cannulas. We proved that HMR1426 is not a CCKA agonist. CONCLUSION: The correlation between anorectic properties of HMR1426 and gastric emptying suggests that gastric emptying may cause the anorectic properties of HMR1426. The differences in microstructural feeding behavior between HMR1426 and centrally active anorectics makes it unlikely that HMR1426 acts via the CNS. Evidence for a peripheral mode of action is derived from sham-fed rats with open gastric fistula. When the milk fed was drained, HMR1426 was ineffective. HMR1426 is not a CCKA agonist. The molecular action of HMR1426 causing gastric emptying and its anorectic properties are under investigation.
引用
收藏
页码:211 / 221
页数:11
相关论文
共 27 条
[1]  
ALI HMM, 1998, JAMA-J AM MED ASSOC, V282, P1519
[2]   Urocrotin reduces food intake and gastric emptying in lean and ob/ob obese mice [J].
Asakawa, A ;
Inui, A ;
Ueno, N ;
Makino, S ;
Fujino, MA ;
Kasuga, W .
GASTROENTEROLOGY, 1999, 116 (06) :1287-1292
[3]  
*AV PHARM DEUTSCHL, 1999, 9838723871 NOVASCREE
[4]  
*AV PHARM DEUTSCHL, 1999, 91 CER CELL BIOL REC
[5]  
BICKEL M, 2000, INT J OBES RELAT S1, V24, pA413
[6]  
Bignon E, 1999, J PHARMACOL EXP THER, V289, P752
[7]   Current and potential drugs for treatment of obesity [J].
Bray, GA ;
Greenway, FL .
ENDOCRINE REVIEWS, 1999, 20 (06) :805-875
[8]   Pharmacotherapy of obesity: targets and perspectives [J].
Chiesi, M ;
Huppertz, C ;
Hofbauer, KG .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2001, 22 (05) :247-254
[9]   A SIMPLIFIED METHOD FOR ASSESSING DRUG EFFECTS ON GASTRIC-EMPTYING IN RATS [J].
DROPPLEMAN, DA ;
GREGORY, RL ;
ALPHIN, RS .
JOURNAL OF PHARMACOLOGICAL METHODS, 1980, 4 (03) :227-230
[10]  
ERNI W, 1977, ARZNEIMITTEL-FORSCH, V27, P1043